CLINICAL_TRIALS
trial_result
· 2026-03-12
Clinical Trial Update: Post-market Study of the Biodesign Hernia Graft
Summary
A post-market evaluation of the Biodesign Hernia Graft for ventral hernia was terminated, with results posted on 2026-03-12.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cook Biotech Incorporated | Conditions: Ventral Hernia | Status: TERMINATED | Results posted: 2026-03-12